Clinical Trial Update: Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eletriptan for treating migraine in patients with prior poor response or intolerance to oral sumatriptan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with or Without Aura

Drugs mentioned

• Eletriptan (eletriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine With or Without Aura | Phase 3 | Status: COMPLETED